Clinical T

This input is used for staging

Notes

**Note 1:** Assign 88 for in situ cases (behavior code /2). TNM nor FIGO include an in situ category for sarcomas of the corpus. **Note 2:** When both the Federation Internationale de Gynecologie et d'Obstetrique (FIGO) stage and extension information on the primary tumor are available, use the extension information to assign the T in preference to a statement of FIGO stage - see Registrar notes. * If the only information is FIGO III [NOS] or IIIC, assign the appropriate stage and leave clinical T, N, and M blank. If the only information is FIGO stage IVB, leave T and N blank and see M **Note 3:** Extension to the bowel or bladder mucosa must be proven by biopsy in order to rule out bullous edema.

NAACCR Item

NAACCR #940
Clinical T Clinical T Display Description Registrar Notes
cX cTX Not defined by UICC* Primary tumor cannot be assessed

Clinical classification criteria met, evaluation done:
Physician unable to assess T
Extension cannot be determined OR
Physician assigns cTX, no other information available to determine T
c0 cT0 Not defined by UICC** No evidence of primary tumor
c1 cT1 Tumor limited to the uterus Note: T1 has subcategories of T1a, T1b and T1c. Assign T1 only when there is no information available to assign one of the subcategories.

Invasive cancer confined to corpus uteri

Invasion of myometrium, NOS WITH or WITHOUT involvement of endocervix

Tunica serosa of the visceral peritoneum (serosa covering the corpus)

Cervix uteri, NOS, but not beyond uterus

Localized, NOS

FIGO Stage I [NOS]

Stated as T1 [NOS]
c1A cT1a Tumor limited to the endometrium/endocervix Confined to endometrium OR endocervix (Glandular, stromal or both)

FIGO Stage IA

Stated as T1
c1B cT1b Tumor invades less than half of the myometrium Tumor invades less than one-half of myometrium WITH involvement of endocervix

FIGO Stage IB

Stated as T1b
c1C cT1c Tumor invades one half or more of the myometrium Invasion of outer half of myometrium WITH involvement of endocervix

FIGO Stage IC

Stated as T1c
c2 cT2 Tumor extends beyond the uterus, within the pelvis Note: T2 has subcategories of T2a and T2b. Assign T2 only when there is no information available to assign one of the subcategories.

FIGO Stage II [NOS]

Stated as T2 [NOS]
c2A cT2a Tumor involves adnexa Adnexal involvement, NOS
Extension or metastasis within true pelvis:
Adnexa
Fallopian tube(s)
Ligaments:
Broad
Round
Uterosacral
Ovary(ies)
Parametrium
Visceral peritoneum of pelvic organs excluding serosa of corpus uteri

FIGO Stage IIA

Stated as T2a
c2B cT2b Tumor involves other pelvic tissues Extension or metastasis to:
Cul de sac (rectouterine pouch)
Pelvic wall(s)
Parietal serosa of pelvic cavity
Ureter
Vagina
Vulva

Described clinically as "frozen pelvis", NOS

FIGO Stage IIB

Stated as T2b
c3 cT3 Tumor involves abdominal tissues Note: T3 has subcategories of T3a and T3b. Assign T3 only when there is no information available to assign one of the subcategories.

Abdominal tissues involvement, NOS

Further contiguous extension

Stated as T3 [NOS]
c3A cT3a One site Infiltration of abdominal tissues, one of the following sites:
Abdominal serosa (visceral or parietal peritoneum of abdomen)
Sigmoid colon
Small intestine
Other abdominal structures

FIGO Stage IIIA

Stated as T3a
c3B cT3b More than one site FIGO Stage IIIB

Stated as T3b
c4 cT4 Tumor invades bladder or rectal mucosa Invasion of:
Bladder wall
Bladder, NOS excluding mucosa
Rectal wall
Rectum, NOS excluding mucosa

Extension to bowel mucosa or bladder (excluding bullous edema)

FIGO Stage IVA

Stated as T4
88 88 Not applicable In situ case but no pTis is defined by TNM
Death certificate only (DCO) case
<BLANK> BLANK See Registrar Notes Only information is FIGO Stage III [NOS], IIIC, or IVB

Clinical classification not met
Clinical classification criteria met, evaluation done:
No information about diagnostic workup
Results not documented in record
Clinical evaluation of primary tumor not done or unknown if done
Tumor first detected on surgical resection (no clinical workup)
Evidence of metastatic disease [(cM1) or (pM1)], no other workup
\* TX is not defined by UICC in the 7th edition. Approval has been provided by UICC to use the standard definition "Primary tumor cannot be assessed," as TX. \** T0 is not defined by UICC in the 7th edition. Approval has been provided by UICC to use the standard definition "No evidence of primary tumor," as T0.